dacarbazine has been researched along with Arachnoidal Cerebellar Sarcoma, Circumscribed in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (8.11) | 18.7374 |
1990's | 1 (2.70) | 18.2507 |
2000's | 11 (29.73) | 29.6817 |
2010's | 22 (59.46) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bautista, F; Carceller, F; de Rojas, T; Fioravantti, V; Lassaletta, A; Madero, L; Moreno, L | 1 |
Bauer, D; Biassoni, V; Casanova, M; Catania, S; De Pava, MV; Gandola, L; Indini, A; Massimino, M; Modena, P; Pecori, E; Podda, M; Polastri, D; Rampini, P; Schiavello, E | 1 |
Aerts, I; Bailey, S; Breazna, A; Cañete, A; Cisar, L; de Toledo Codina, JS; Dorman, A; Estlin, E; Geoerger, B; Gesner, L; Grill, J; Grundy, RG; Hargrave, D; Leblond, P; Madero, L; Nicolin, G; Perek, D; Verlooy, J | 1 |
Kaoru, K; Kazuhiko, S; Koji, I; Takeshi, N; Toshikazu, H | 1 |
Abate, ME; Barone, G; Cefalo, G; Colosimo, C; Garrè, ML; Madon, E; Mascarin, M; Massimino, M; Perilongo, G; Potepan, P; Riccardi, R; Ridola, V; Ruggiero, A; Spreafico, F | 1 |
Cloughesy, TF; Kornblum, HI; Laks, DR; Lasky, JL; Lee, WN; Lin, HJ; Moore, TB; Pak, Y; Panosyan, EH; Wang, Y; Xia, P | 1 |
Bradshaw, TD; Coyle, B; Grundy, RG; Kerr, ID; Kimishi, I; Korshunov, A; Othman, RT; Pfister, SM; Storer, LC | 1 |
Furukawa, G; Marco Antonio, DS; Moreira, JC; Okamoto, OK; Rodini, CO; Santos, MC; Silva, PB; Zanotto-Filho, A | 1 |
Ashikaga, T; Bergendahl, G; DeSarno, M; Eslin, D; Ferguson, W; Hanna, GK; Higgins, T; Kaplan, J; Kraveka, J; Mitchell, D; Roberts, W; Sholler, GL; Werff, AV | 1 |
Brassesco, MS; Delsin, LE; Pezuk, JA; Scrideli, CA; Tone, LG; Valera, ET | 1 |
Baryawno, N; Calero, R; Darabi, A; Dyberg, C; Einvik, C; Johnsen, JI; Kogner, P; Kool, M; Milosevic, J; Sandén, E; Siesjö, P; Sveinbjörnsson, B; Wickström, M | 1 |
Battiste, JD; Bonney, PA; Maurer, AJ; McNall-Knapp, RY; Santucci, JA; Sughrue, ME | 1 |
Chang, KP; Hsu, TR; Wang, CH; Wong, TT | 1 |
Estlin, EJ; McGown, A; Najim, N; Podmore, ID | 1 |
Attinà, G; Bertolini, P; Colosimo, C; Lazzareschi, I; Mastrangelo, S; Maurizi, P; Migliorati, R; Pastore, M; Riccardi, R; Rizzo, D; Ruggiero, A | 1 |
Arnold, L; Faoro, D; Gerber, NU; Grotzer, MA; Haybaeck, J; Hegi, M; Hürlimann, ML; Mittelbronn, M; Rutkowski, S; Sciuscio, D; Shalaby, T; von Bueren, AO | 1 |
Boddy, AV; Castelbuono, DJ; Clifford, SC; Curtin, NJ; Daniel, RA; Drew, Y; Hostomsky, Z; Mulligan, EA; Plummer, ER; Rozanska, AL; Thomas, HD; Tweddle, DA | 1 |
Aguilera, DG; Fangusaro, J; Goldman, S | 1 |
Lin, F; Lin, J; Rao, J; Sheng, H; Yang, L; Yin, B; Zhang, N; Zhou, H | 1 |
Andre, N; Chinot, O; Cowen, D; Figarella Branger, D; Gentet, JC; Muracciole, X; Padovani, L; Scavarda, D; Verschuur, A | 1 |
Li, S; Liu, Y; Sun, P; Ying, H | 1 |
Escalon, E; Melnick, SJ; Nair, SM; Ramachandran, C | 1 |
Bacolod, MD; Fedier, A; Friedman, HS; Grotzer, MA; Hagel, C; Heinimann, K; Kool, M; Kordes, U; Koster, J; Marra, G; Pietsch, T; Rutkowski, S; von Bueren, AO | 1 |
Aguilera, D; Castellino, RC; Fangusaro, J; Hayes, LL; Kim, S; MacDonald, TJ; Mazewski, C; McNall-Knapp, RY | 1 |
Billups, C; Cheshire, PJ; Fouladi, M; Friedman, HS; Houghton, PJ; Leggas, M; Peterson, JK; Stewart, CF; Woo, MH | 1 |
Chiamchanya, S; Dhanachai, M; Hongeng, S; Laothamatus, J; Visudtibhan, A | 1 |
DeAngelis, LM | 1 |
Ali-Osman, F; Bigner, DD; Cheng, CL; Dolan, ME; Friedman, HS; Johnson, SP; Keir, ST; Li, H; Modrich, P; Quinn, JA; Salzman, AL; Szabo, C | 1 |
Sawamura, Y | 1 |
Bernstein, M; Fort, D; Friedman, H; Harris, MB; Kadota, R; Krailo, M; Kretschmar, CS; Mazewski, C; Nicholson, HS; Reaman, GH; Sato, J; Tedeschi-Blok, N | 1 |
Bernsen, HJ; Poelen, J; Prick, MJ | 1 |
Bay, JO; Durando, X; Gilliot, O; Irthum, B; Thivat, E; Verrelle, P; Vincent, C | 1 |
Burger, PC; Cochran, EJ; Gujrati, M; Holland, EC; Huse, JT; Jost, SC; Miller, CR; Perry, A; Qian, J; Raghavan, R; Rosenblum, MK; Scheithauer, BW; Zambrano, SC | 1 |
Cottu, PH; Epardeau, B; Espie, M; Extra, JM; Giacchetti, S; Marty, M; Mignot, L; Visot, B | 1 |
Levin, VA; Wilson, CB | 1 |
Bleyer, WA; Geyer, JR; Heideman, RL; Kosnik, EJ; Milstein, JM; Morris, JD; Mulne, AF; Pendergrass, TW; Ruymann, FB; Stuntz, JT | 1 |
Brunat-Mentigny, M; Chastagner, P; Czorny, A; Lapras, C; Olive, D; Philip, T; Zucker, JM | 1 |
4 review(s) available for dacarbazine and Arachnoidal Cerebellar Sarcoma, Circumscribed
Article | Year |
---|---|
Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update.
Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dacarbazine; Humans; Medulloblastoma; Molecular Targeted Therapy; Smoothened Receptor; Temozolomide | 2017 |
[Chemotherapy for gliomas in children].
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Glioma; Humans; Infant; Medulloblastoma; Temozolomide | 2005 |
High dose chemotherapy with stem-cell transplantation in a metastatic medulloblastoma in an adult: a case report and review of the literature.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cerebellar Neoplasms; Combined Modality Therapy; Dacarbazine; Doxorubicin; Humans; Male; Mechlorethamine; Medulloblastoma; Prednisone; Procarbazine; Stem Cell Transplantation; Vinblastine; Vincristine | 1994 |
Chemotherapy: the agents in current use.
Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Dacarbazine; Drug Therapy, Combination; Glioma; Humans; Lomustine; Medulloblastoma; Methotrexate; Nitrogen Mustard Compounds; Procarbazine; Semustine; Teniposide; Vincristine | 1975 |
5 trial(s) available for dacarbazine and Arachnoidal Cerebellar Sarcoma, Circumscribed
Article | Year |
---|---|
Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cerebellar Neoplasms; Child; Child, Preschool; Dacarbazine; Female; Humans; Irinotecan; Male; Medulloblastoma; Temozolomide | 2013 |
Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Cerebellar Neoplasms; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; Female; Humans; Italy; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Temozolomide; Young Adult | 2014 |
A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dacarbazine; Female; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Medulloblastoma; Neoplasm Recurrence, Local; Neuroblastoma; Taxoids; Temozolomide | 2016 |
Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Dacarbazine; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Medulloblastoma; Neoplasm Recurrence, Local; Temozolomide; Treatment Outcome | 2010 |
Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Central Nervous System Neoplasms; Child; Child, Preschool; Dacarbazine; Drug Administration Schedule; Ependymoma; Female; Humans; Infant; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Temozolomide; Treatment Outcome | 2007 |
28 other study(ies) available for dacarbazine and Arachnoidal Cerebellar Sarcoma, Circumscribed
Article | Year |
---|---|
Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cranial Irradiation; Dacarbazine; Deoxycytidine; Disease Progression; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Irinotecan; Male; Medulloblastoma; Melphalan; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Patient Selection; Quality of Life; Radiotherapy; Retrospective Studies; Salvage Therapy; Temozolomide; Young Adult | 2013 |
A case of adult onset medulloblastoma during maintenance chemotherapy for anaplastic astrocytoma one year after radiotherapy.
Topics: Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Chemoradiotherapy; Combined Modality Therapy; Dacarbazine; Epilepsy, Complex Partial; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Maintenance Chemotherapy; Male; Medulloblastoma; Temozolomide; Tomography, X-Ray Computed | 2013 |
Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Asparagine; Aspartate-Ammonia Ligase; Brain Neoplasms; Cell Growth Processes; Cell Line, Tumor; Dacarbazine; DNA Damage; Drug Synergism; Glioblastoma; Glutamine; Humans; Male; Medulloblastoma; Mice; Mice, Nude; Temozolomide; Xenograft Model Antitumor Assays | 2014 |
Overcoming multiple drug resistance mechanisms in medulloblastoma.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cells, Cultured; Cerebellar Neoplasms; Child; Child, Preschool; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Indoles; Male; Medulloblastoma; Minor Histocompatibility Antigens; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Temozolomide; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2014 |
Embryonic Stem Cell-Related Protein L1TD1 Is Required for Cell Viability, Neurosphere Formation, and Chemoresistance in Medulloblastoma.
Topics: AC133 Antigen; Antigens, CD; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dacarbazine; Glycoproteins; Humans; Medulloblastoma; Nestin; Neural Stem Cells; Peptides; Proteins; Temozolomide | 2015 |
The Antiproliferative and Pro-apoptotic Effects of Methoxyamine on Pediatric Medulloblastoma Cell Lines Exposed to Ionizing Radiation and Chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Apoptosis; Caspases; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms; Child; Cisplatin; Dacarbazine; DNA Repair; Humans; Hydroxylamines; Medulloblastoma; Radiation-Sensitizing Agents; Radiation, Ionizing; Temozolomide; Thiotepa; Tumor Stem Cell Assay | 2015 |
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.
Topics: Animals; Antineoplastic Agents; Benzeneacetamides; beta Catenin; Brain Neoplasms; Camptothecin; Celecoxib; Cisplatin; Colorectal Neoplasms; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Doxorubicin; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; Glucose-6-Phosphate Isomerase; Heterocyclic Compounds, 3-Ring; Humans; Immunoblotting; Immunohistochemistry; Irinotecan; Medulloblastoma; Mice; Neoplasm Transplantation; Neoplasms; Neuroblastoma; Pyrans; Pyrazines; Pyridines; Real-Time Polymerase Chain Reaction; Sulfones; Temozolomide; Triazoles; Tumor Suppressor Proteins; Vincristine; Wnt Proteins; Wnt Signaling Pathway | 2015 |
Dramatic response to temozolomide, irinotecan, and bevacizumab for recurrent medulloblastoma with widespread osseous metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Camptothecin; Cerebellar Neoplasms; Dacarbazine; Female; Humans; Irinotecan; Medulloblastoma; Temozolomide; Young Adult | 2016 |
Efficacy of temozolomide for recurrent embryonal brain tumors in children.
Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Female; Follow-Up Studies; Headache; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Nausea; Neuroectodermal Tumors, Primitive; Rhabdoid Tumor; Temozolomide; Teratoma; Treatment Outcome; Vomiting | 2009 |
Methionine restriction reduces the chemosensitivity of central nervous system tumour cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Proliferation; Cerebellar Neoplasms; Cisplatin; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Fluorometry; Glioma; Glutathione; Humans; Medulloblastoma; Methionine; Methotrexate; Temozolomide; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2009 |
Expression of O⁶-methylguanine-DNA methyltransferase in childhood medulloblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Proliferation; Cerebellar Neoplasms; Child; Child, Preschool; Dacarbazine; DNA Methylation; Female; Gene Expression Regulation, Enzymologic; Humans; Immunoenzyme Techniques; Lomustine; Male; Medulloblastoma; Multicenter Studies as Topic; Neuroectodermal Tumors, Primitive; O(6)-Methylguanine-DNA Methyltransferase; Prognosis; Promoter Regions, Genetic; Prospective Studies; Randomized Controlled Trials as Topic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Temozolomide | 2011 |
Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Division; Cell Line, Tumor; Cell Survival; Central Nervous System Neoplasms; Child; Dacarbazine; DNA Mismatch Repair; DNA Repair; Humans; Indoles; Medulloblastoma; Mice; Mice, Nude; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Protein Serine-Threonine Kinases; Temozolomide; Transplantation, Heterologous | 2010 |
Bevacizumab and irinotecan in the treatment of children with recurrent/refractory medulloblastoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Child; Child, Preschool; Dacarbazine; Drug Resistance, Neoplasm; Female; Humans; Irinotecan; Magnetic Resonance Imaging; Male; Medulloblastoma; Neoplasm Recurrence, Local; Salvage Therapy; Temozolomide; Treatment Outcome | 2011 |
The insulin-like growth factor-I receptor kinase inhibitor NVP-ADW742 sensitizes medulloblastoma to the effects of chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Separation; Dacarbazine; Flow Cytometry; Humans; Inhibitory Concentration 50; Medulloblastoma; Polymerase Chain Reaction; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Temozolomide | 2011 |
Reirradiation and concomitant metronomic temozolomide: an efficient combination for local control in medulloblastoma disease?
Topics: Administration, Metronomic; Adolescent; Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Child; Dacarbazine; Fatal Outcome; Female; Humans; Male; Medulloblastoma; Radiation Dosage; Retreatment; Temozolomide; Young Adult | 2011 |
Action of db-cAMP on the bystander effect and chemosensitivity through connexin 43 and Bcl-2-mediated pathways in medulloblastoma cells.
Topics: Animals; Antineoplastic Agents; Bucladesine; Bystander Effect; Cell Line, Tumor; Cell Survival; Cerebellar Neoplasms; Connexin 43; Dacarbazine; Drug Screening Assays, Antitumor; Drug Synergism; Gap Junctions; Gossypol; Humans; Medulloblastoma; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcl-2; Rats; Signal Transduction; Simplexvirus; Temozolomide; Teniposide; Thymidine Kinase | 2012 |
Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force™ in brain tumor cell lines.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms; Curcuma; Curcumin; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Glioblastoma; Humans; Inhibitory Concentration 50; Medulloblastoma; Phytotherapy; Plant Extracts; Plants, Medicinal; Rhizome; Temozolomide | 2012 |
Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cerebellar Neoplasms; Child; Child, Preschool; Dacarbazine; DNA Mismatch Repair; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Female; Humans; Male; Medulloblastoma; MutL Protein Homolog 1; Nuclear Proteins; O(6)-Methylguanine-DNA Methyltransferase; Temozolomide; Tumor Suppressor Proteins | 2012 |
Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience.
Topics: Adolescent; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Camptothecin; Child; Child, Preschool; Dacarbazine; Drug Administration Schedule; Female; Humans; Infant; Irinotecan; Male; Medulloblastoma; Recurrence; Retrospective Studies; Temozolomide; Treatment Outcome | 2013 |
Relation between Irofulven (MGI-114) systemic exposure and tumor response in human solid tumor xenografts.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Chromatography, High Pressure Liquid; Cyclophosphamide; Dacarbazine; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Glioblastoma; Glioma; Humans; Medulloblastoma; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Mice, SCID; Neoplasms; Neuroblastoma; Neuroectodermal Tumors, Primitive; Radiation Chimera; Random Allocation; Rhabdoid Tumor; Rhabdomyosarcoma, Embryonal; Sesquiterpenes; Tumor Cells, Cultured; Vincristine; Xenograft Model Antitumor Assays | 2002 |
Treatment of leptomeningeal relapse of medulloblastoma with temozolomide.
Topics: Brain; Child; Dacarbazine; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Recurrence; Temozolomide | 2002 |
Chemotherapy for brain tumors--a new beginning.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Dacarbazine; Gene Silencing; Glioblastoma; Humans; Medulloblastoma; O(6)-Methylguanine-DNA Methyltransferase; Survival Analysis; Temozolomide | 2005 |
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft.
Topics: Animals; Antineoplastic Agents, Alkylating; Base Pair Mismatch; Dacarbazine; DNA Repair; Drug Resistance, Neoplasm; Indoles; Medulloblastoma; Mice; Mice, Inbred BALB C; Mice, Nude; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Temozolomide; Transplantation, Heterologous; Tumor Cells, Cultured | 2005 |
Metastatic medulloblastoma in an adult; treatment with temozolomide.
Topics: Adult; Antineoplastic Agents, Alkylating; Cerebellar Neoplasms; Dacarbazine; Female; Humans; Magnetic Resonance Imaging; Medulloblastoma; Neoplasm Recurrence, Local; Spinal Cord Neoplasms; Temozolomide | 2007 |
Temozolomide treatment of an adult with a relapsing medulloblastoma.
Topics: Adult; Antineoplastic Agents, Alkylating; Cerebellar Neoplasms; Dacarbazine; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Neoplasm Recurrence, Local; Radionuclide Imaging; Temozolomide; Treatment Outcome | 2007 |
Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Female; Follow-Up Studies; Genes, myc; Glioma; Humans; In Situ Hybridization, Fluorescence; Medulloblastoma; Neoplasm Metastasis; Neoplasms, Multiple Primary; Neuroectodermal Tumors, Primitive; Prognosis; Proto-Oncogene Proteins; Radiotherapy; Temozolomide; Treatment Outcome; Young Adult | 2009 |
Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Drug Evaluation; Glioblastoma; Humans; Hydroxyurea; Lomustine; Medulloblastoma; Methylprednisolone; Neoplasm Recurrence, Local; Procarbazine; Vincristine | 1987 |
[Efficacy of the "8 drugs in a day" protocol in brain tumors in children].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cytarabine; Cytidine Diphosphate Diglycerides; Dacarbazine; Female; Glioma; Humans; Hydroxyurea; Infant; Lomustine; Male; Medulloblastoma; Methylprednisolone; Procarbazine; Vincristine | 1988 |